CIMG Inc.(NASDAQ:IMG),founded on July 15,2011,was listed on the NASDAQ Stock Exchange in the United States on June 19,2020.

CIMG Inc. is a global digital health and sales company, which focuses on digital marketing, sales, and distribution of various consumer goods related to food and beverages. Dedicated to reshaping the digital marketing and distribution with artificial intelligence applications, the Company endeavors to create greater commercial value for its business partners and therefore enhance its own enterprise value and shareholders’ value of their stake in the Company.

The Company has a professional brand and marketing management system, which can quickly help partnering enterprises achieve the connection, management, and operation of marketing channels domestically and globally. The company's products include maca peptide coffee, Maca Noni beverages, maca purified powder, and qianmao wine.

CIMG Inc. Commercial Value

Leading the global health industry to rapidly achieve digital and large-scale development, and expanding unlimited commercial possibilities for cooperative enterprises!

Profound industry insights
A strategic plan with meticulous layout
Forward and innovative thinking
CIMG Inc. Core team
Jianshuang Wang
(Chairman of the Board of Directors & Co-Chief Executive Officer)

Ms. Jianshuang Wang joined a U.S. listed company (then WeTrade Group Inc., former ticker symbol “WETG,” and now Next Technology Holding Inc. under current ticker symbol “NXTT”) in 2021 and has been serving as the legal representative of its Chinese subsidiary and the director of its Hong Kong subsidiary. During her tenure, she has been responsible for human resources management and supervising the administrative and operational management.

Yanli Hou
(Independent Director)

Ms. Yanli Hou,Executive Director of DaRen International (01957.HK).He has always focused onstudying the development of the Internet industry.and has served as the management position ofseveral Internet enterprises.He has successivelyserved as the President of the Live Business Group.

Mr. Changzheng Ye
(Director)

Changzheng Ye,33,holds a Bachelor’s degree in Mold Design and Manufacture from Zhengzhou University, which he earned between 2011 and 2014.His professional experience includes roles as an Engineer at Shanghai Volkswagen from 2014 to 2015, a Software Engineer at Shanyi Shanmei Technology Co.,Ltd from 2015 to 2017, a Project Manager at Shenzhen Baoyide Network Technology Co.,Ltd from 2018 to 2021,and a Technical Director at Enron Investment Management from 2021 to 2023.Since March 2023, he has been serving as the Technical Director at Lear Group Limited.

Mr. Jian Liu
(Director)

Mr. Jian Liu has been serving as the Design Directorand Operations Director at MBV International Limited(01957. HK) since 2020. During his tenure, he undertook design work and also gained extensive experience in market operations. Mr. Jian Liu is familiar with marketing strategies and promotion skills to effectively expand the market and enhance the company's reputation. Mr. Jian Liu graduated from Shandong Fashion University with a major in Visual Communication in 2014. From 2014 to 2020,he worked at Beijing Zhouji Technology Co. , Ltd.and Zhengbang Creative(Beijing) Brand Technology Co., Ltd.

Ms. Zongmei Huang
(Director)

Ms. Huang previously held senior management positions at PPS Baolian Company and ISS World Company in Hong Kong. Since 2019, she has served as the CEO of XinRui Technology Co. , Limited, a Hong Kong-based company that invests in the fully globalized technology industry. Its main focus is to assist Chinese companies in expanding their global business overseas. Through various means such as venture capital and private equity, it helps Chinese technology companies in the growth cycle achieve their global development strategy. XinRui's investment field focuses on digital scenarios, covering multiple areas such asenterprise services, cloud services, network security, financial technology, cross-border supply chain, retail consumption, e-commerce, logistics, and digital entertainment.

Market Analysis and Development Trends
1. Global Health Industry Market Size: According to statistical data, the global health industry market size reached $1.5 trillion in 2022, and is estimated to reach $2.5 trillion by 2025.
2. Main markets: The United States, China, Europe and other regions are the main markets for the global health industry, with the Chinese market growing the fastest.
3. Digitization and Intelligence: With the continuous development of information technology, the big health industry is shifting towards digitalization and intelligence. For example, the application of health management platforms, intelligent medical devices, etc. will become an important trend for future development.
Market Analysis

In China, 62% of consumers consider health asa top priority in their daily lives; This proportionis significantly higher than the United States(41%)and the United Kingdom(29%).

Compared to a year ago,more Chineseconsumers place greater emphasis on health.

In the sampling survey, when asked if healthexpenditures would be adjusted if the overalconsumption level decreased, 74% of consumersanswered that they would increase or increaserelated expenditures on health productconsumption.

Market Analysis

With the trend of general health and the gradual expansion of the big health industry market, organic, functional drinks, and natural healthy foods are gradually merging into the big health track.

The map of the big health industry is constantly expanding!
CIMG Inc.Agent Product Introduction

CIMG Inc.exclusively sells all maca products produced by Asia's largest maca production base. Including: maca peptide coffee, maca nori fruit beverage, maca wine, maca purification powder and other full range products.

The advantages of CIMG Inc. agency products
Growing in the only planting base in the country, natural and pure

The Maca Mountain Planting Base is located in a high-altitude ecological planting base, in the southern section of the Yulong Snow Mountain in Lijiang. It is situated at 27 ° 03'20 '-27 ° 40' N and 100 ° 04'10 '-100 ° 16'30' E. At the southern end of the Qinghai Tibet Plateau in China, Peruvian Maca is suitable for planting in Asia and is the only planting base in the country that can produce high-quality Maca. The planting base covers an area of approximately 30000 acres.

The unique geographical environment provides favorable conditions for the growth of maca, and its geographical environment, climate, sea level, and soil are very similar to those of the Andes Mountains in Peru. There were foreign botanists stationed in Lijiang to study the planting project of maca, so there are abundant wild maca in the snow mountain area. The nutritional composition of maca in this area has reached the level of Peruvian maca according to the determination of the Institute of Process Engineering of the Chinese Academy of Sciences. It is reported that maca growing in this area is the only place in China that can provide authentic maca raw materials.

The advantages of CIMG Inc. agency products
Scientific blending and additive free canned sterilization technology
Export certified products that meet international standards

Maca undergoes enzymatic hydrolysis, extraction, and two rounds of centrifugal slurry separation. The required water treatment reaches the medical grade, and is carefully and scientifically formulated to a certain volume. After being sterilized at 121.5 degrees Celsius (without adding any preservatives), it undergoes sterilization.

To ensure quality, sterile hot filling is used. After sterilization and cooling to 85 degrees (ensuring vacuum compliance), the cans are canned at a rate of 13000 cans per hour. After being canned, the cans are pushed back into the sterilization pot at 121.5 degrees Celsius and sterilized together with the cans.

After the cooling and automated equipment inspection of the tank body is qualified, it is packaged and the finished product is transported to the warehouse for maintenance and outbound.

The manufacturing workshop is located in Xinghua, Jiangsu Province. The production line is equipped with integrated biotechnology and beverage equipment, and the production license is also specially approved. It is the only local product that meets international standards and has obtained export certification.

The advantages of CIMG Inc. agency products
The first food and medicine homologous production line in Asia
A single production line can process 13000 cans of can bodies per hour
Formerly a leading production contract manufacturing enterprise of Red Bull
Jiangsu Kangduoyuan Beverage Co., Ltd. has won multiple honors and awards, including the Jiangsu Enterprise Development Engineering Association - Group Member Unit, National Safe Food Promotion Project, and Integrity Demonstration Operator.
Benchmarking product - Red Bull
Red Bull, the pioneer of China's functional beverage market
In 1995, Red Bull entered the Chinese market
By December 2023, China Red Bull's cumulative industrial production has exceeded 58 billion cans
Red Bull is still a super large product with an annual sales revenue of 20 billion yuan in China
Benchmarking Product - Kangaroo Essence
Contact Info:
CEO Email:Alice.Wang@ccmg.tech
PR/IR Email:IR@ccmg.tech